Author

S. Byrne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Chandran· 1 shared A. J. Mentzer· 1 shared A. Karolak· 1 shared A. Marusyk· 1 shared A. Mayer· 1 shared A. McKnight· 1 shared A. Noack· 1 shared A. Otter· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Chandran

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.

M. Milighetti, Y. Peng, C. C. S. Tan, M. Mark, G. Nageswaran, S. Byrne, T. Ronel, T. Peacock, A. Mayer, A. Chandran, J. Rosenheim, M. Wheelan, X. Yao, G. Liu, S. L. Felce, , B. Chain

The paper identifies high frequency naive T cell precursors that drive rapid T cell responses during early SARS-COV-2 and LCMV infections.

bioRxiv · Nov 8, 2022Immunology

DNA Modifications Enabling Proximity Biotinylation

B. Wilbanks, K. Pearson, S. Byrne, L. Bickart, P. Dedon, L. J. Maher

This paper introduces novel methods for proximity biotinylation of exogenous oligodeoxyribonucleotides using enzymatic tools and conjugation chemistries.

bioRxiv · Oct 2, 2022Biochemistry

Accelerated Predictive Healthcare Analytics with Pumas, A High Performance Pharmaceutical Modeling and Simulation Platform

C. V. Rackauckas, Y. Ma, A. Noack, V. Dixit, P. Mogensen, C. Elrod, M. Tarek, S. Byrne, S. Maddhashiya, J. B. S. Calderon, M. Hatherly, J. Nyberg, J. Gobburu, V. Ivaturi

The paper introduces Pumas, a high-performance platform for pharmacometric modeling, showing significant performance improvements in drug development and precision medicine.

bioRxiv · Nov 28, 2020 · PreprintPharmacology & Toxicology

Collagen Production and Niche Engineering: A Novel Strategy for Cancer Cells to Survive Acidosis and Evolve

M. Damaghi, S. Byrne, L. Xu, N. Tafreshi, B. Fang, J. Koomen, A. Karolak, T. Chen, J. Johnson, N. Gallant, A. Marusyk, R. J. Gillies

The paper identifies collagen production as an adaptation strategy in acidotic cancer cells, showing correlation with patient survival.

bioRxiv · Jul 24, 2019Cancer Biology